PubHealth.info® (An Information Portal on Public Health Issues / Topics, Presented in Collaboration with PakMed Biomedical Solutions)

[PubHealth.info Homepage] [Category Homepage] [Disclaimer/Copyrights] [Feedback]


Thank you for your kind visit to PubHealth.info®, an information portal created in technical collaboration with PakMed Biomedical Solutions * * * PubHealth.info® presents hundreds of thousands of informative Web pages on a variety of public health issues / issues * * * An ultimate source of information for teachers, students and research workers who need to find information on various public health issues, like population planning, contraception, HIV AIDS, STDs, maternal and child health, communicable and non-communicable disease, etc. * * * PubHealth.info® regularly updates the repository of these hundreds of thousands of informative Web pages * * * PubHealth.info® is one of the world's largest repositories and information portals with online Web pages on public health issues particularly those pertaining to developing countries!

PubHealth.info® (a subsidiary of PakMed) presents scientific information mainly based on abstracts of articles published on a variety of public health issues/topics, particularly encompassing population planning, disease prevention, maternal and child health, and communicable and non-communicable diseases (like HIV AIDS, malaria, etc) that are affecting a significant portion of population in developing and developed countries. Here you can find abstracts of articles published on a variety of public health topics under category "Contraception (Birth Control) and Family Planning". Contraception (birth control) is a regimen of one or more actions, devices, or medications followed in order to deliberately prevent or reduce the likelihood of a woman becoming pregnant or giving birth. Therefore contraception is the utilization of various and sundry surgical procedures, devices, practices, agents, or drugs with the intention of preventing conception or impregnation (pregnancy). Methods and intentions typically termed birth control may be considered a pivotal ingredient to family planning. Birth control is a controversial political and ethical issue in many cultures and religions, and although it is generally less controversial than abortion specifically.

Here you can find more than 42,000 article titles on "Contraception (Birth Control) and Family Planning" , along with their abstracts and bibliographic information (one of the world's largest collections of article titles on this topic), mentioned in various lists that are sorted/arranged according to the years of publication. You can view the bibliographic details and abstracts of these articles, by clicking the title of your required article. To view other lists of articles in the same category "Contraception (Birth Control) and Family Planning", please visit "Category Lists Homepage" or select a list from the following dropdown list of article titles.

 

List 42: Articles 20501-21000 (500 Articles)

To view other lists in the same category, please VISIT LISTS HOME PAGE or select a list from the above dropdown list of article titles
  1. Future aspects in contraception.
  2. Future development of synthetic estrogens and progestagens for contraception.
  3. Gender and oral contraceptive effects on temporary auditory effects of noise.
  4. Gender and oral contraceptive steroids as determinants of drug glucuronidation: effects on clofibric acid elimination.
  5. Gender roles and premarital contraception.
  6. General discussion [of factors affecting acceptance and compliance in use of oral contraception]
  7. Glutathione and caffeine antagonize the sperm-immobilizing effect of a vaginal contraceptive.
  8. Gossypol as a male oral contraceptive: trial case report.
  9. Growth and change in a family planning agency: a multi-strategy approach to well-being in the eighties.
  10. Guidelines on communication support programme for family planning field workers in Vietnam.
  11. Guidelines on vasectomy and oral contraceptives.
  12. Guiding adolescents' choice of a contraceptive.
  13. Health and family planning.
  14. The health belief model and teenage contraceptive behavior: from theory to operation.
  15. The health of women and contraception in Quebec.
  16. The health rationale for family planning in North Africa with special reference to Egypt.
  17. Health reasons for family planning in Latin America. [Razones de salud para la planificacion familiar en Latinoamerica.]
  18. Hemolytic uremic syndrome due to combined oral contraceptives(letter)[. [Sindrome hemolitico uremico por anticonceptivos orales compuestos por estrogenos-progestagenos.]
  19. Hemolytic-uremic syndrome associated with oral contraceptives: 2 cases. [Sindrome hemolitico uremico asociado a la toma de anovulatorios. A proposito de dos casos.]
  20. Hepatic adenomas and oral contraceptives. [Adenomas hepaticos y anticonceptivos orales.]
  21. Hepatic complications of oral contraceptives. [Complications hepatiques des contraceptifs oraux.]
  22. Hepatic infarction related to oral contraceptive use.
  23. Hepatic pathology caused by the association of cyclosporin A with an oral contraceptive. [Arzneimittelschadigung der Leber bei Kombination von Cyclosporin A und einem Antikonzeptivum.]
  24. Hepatic tumors and oral contraceptives. [Tumeurs hepatiques et contraceptifs oraux.]
  25. Hepatic tumors and oral contraceptives: clinicopathologic spectrum in four patients. [Tumores hepaticos y anticonceptivos orales: espectro clinicopatologico en cuatro pacientes.]
  26. Hindu view of family planning and abortion.
  27. A historical overview of the implementation of oral contraception in Singapore.
  28. Historical overview of the implementation of oral contraception in Thailand.
  29. History of family planning in Sierra Leone.
  30. The history of the contraceptive sheath. [L'historique des preservatifs.]
  31. Hormonal contraception and breast cancer.
  32. Hormonal contraception and IUDs in adolescents. [Hormonale Kontrazeption und IUDs bei Jugendlichen.]
  33. Hormonal contraception. [Anticoncepcion hormonal.]
  34. Hormonal contraception. [Hormonale Kontrazeption.]
  35. Hormonal contraceptives and arterial hypertension. [Hormonalne srodki antykoncepcyjne a nadcisnienie tetnicze.]
  36. Hormonal contraceptives in female rowers. [Hormonalni kontraceptiva u veslarek.]
  37. Hormonal contraceptives: past, present, and future.
  38. Hormonal effects of GnRH agonist in the human male: an approach to male contraception using combined androgen and GnRH agonist treatment.
  39. The hormonal ring. A new contraceptive gains acceptance.
  40. The hormonal ring: a new contraceptive gains acceptance.
  41. A hormone contraceptive for men.
  42. How family planning availability affects contraceptive use: the case of Thailand.
  43. How integration of family planning and maternal and child health should be initiated and developed.
  44. How to choose an oral contraceptive in 1984. [Les criteres de choix d'un contraceptif oral en 1984.]
  45. Human dynamics in inter-agency coordination of family planning programmes in Turkey.
  46. The human respiratory nasal mucosa in females using contraceptive pills. An ultramicroscopic and histochemical study.
  47. The human right to family planning. Report of the Working Group on the Promotion of Family Planning as a Basic Human Right to the Members' Assembly and the Central Council of the International Planned Parenthood Federation, November 1983.
  48. Humanistic family planning: the Philippine experience.
  49. Hysteroscopic evaluation of intrauterine progesterone contraceptive system as a treatment for abnormal uterine bleeding.
  50. Ideas and proposals for the further optimization of family planning. [Gedanken und Vorschlage zur weiteren Optimierung der Familienplanung.]
  51. Ideas and questions related to family planning: guide for nurses, midwives and other health personnel. [Notions et questions relatives a la planification familiale. Guide pour infirmiers, sage-femmes et autre personnel de sante.]
  52. Ideas of men and women about contraceptive practices. [Concepcoes de homens e mulheres acerca de praticas contraceptivas.]
  53. Ideology, policy and identity: family planning in a Yemenite community in Israel.
  54. Ignorance of family planning methods in India: an important constraint on use.
  55. Imipramine disposition in users of oral contraceptive steroids.
  56. Immediate postabortal contraception with Norplant: levonorgestrel, gonadotropin, estradiol, and progesterone levels over two postabortal months and return of fertility after removal of Norplant capsules.
  57. Immunological approaches to contraception [abstract]
  58. Immunological aspects of contraceptive steroids.
  59. The impact of accessibility on contraceptive use in rural Thailand.
  60. The impact of accessibility on contraceptive use in rural Thailand.
  61. The impact of family planning practice on neonatal mortality.
  62. The impact of family planning service in rural Yangoru.
  63. The impact of five years of non-physician family planning training in Asia.
  64. The impact of health services on family planning practice.
  65. Impact of integration of family planning with MCH and other development programmes: an action oriented project. Phase-I. 2nd. rev.
  66. The impact of level of knowledge of contraceptive devices and venereal diseases on pelvic infections.
  67. The impact of natural family planning on selected aspects of the couple relationship.
  68. Impact of oral contraceptives upon serum lipoprotein pattern in healthy women.
  69. The impact of policy measures, other than family planning programmes on fertility (the use of the Hungarian longitudinal studies)
  70. The impact of U.S. family planning programs on births, abortions and miscarriages, 1970-1979.
  71. Impacts of behavioral intentions, social support, and accessibility on contraception: a cross-cultural study.
  72. The implementation of federal family planning policy: an analysis of factors affecting state expenditures, fiscal years, 1976-1981.
  73. Implications of future fertility trends for contraceptive practice.
  74. The importance of control groups in testing health and family planning interventions.
  75. Incentive and disincentive programs in Indonesian family planning.
  76. Increasing family planning acceptance through development programs: an experimental study in Northeastern Thailand.
  77. Increasing family planning acceptance through development programs: an experimental study in northeastern Thailand.
  78. The Indonesia Contraceptive Prevalence Survey Report 1983. The results of surveys in five cities.
  79. Indonesia's integrated program facing family planning needs of the future.
  80. Indonesia. B. The building of a successful population-family planning programme.
  81. Indonesia: family planning program. Orientation booklet. 16th ed.
  82. Industrial settings and family planning promotion and services in Bolivia, an operations research project.
  83. Influence exercised by hormonal contraceptives on cycle-dependent changes in size of the uterus. [Die Beeinflussung zyklusabhangiger Grossenveranderungen der Gebarmutter durch Einnahme hormonaler Kontrazeptiva.]
  84. Influence of contraceptive steroids and cigarette smoke on tissue plasminogen activator: a clinical, experimental and immunological study.
  85. Influence of estrogen content of oral contraceptives and consumption of sucrose on insulin, glucose, lactate, and uric acid.
  86. The influence of number of living sons on contraceptive use in rural Egypt.
  87. Influence of nutritional status on pharmacokinetics of contraceptive progestogens.
  88. The influence of oral contraceptives on the frequency of acute appendicitis in different phases of the menstrual cycle.
  89. Influence of psychosocial factors on adolescent compliance with oral contraceptives.
  90. Influence of psychosocial factors on adolescent compliance with oral contraceptives.
  91. Influence of removal of intrauterine contraceptive devices on colonisation of the cervix by actinomyces-like organisms.
  92. Influence of sex, blood group, secretor character, smoking habits, acetylsalicylic acid, oral contraceptives, fasting and general health state on blood coagulation variables in randomly selected young adults.
  93. Information and education in family planning. [Informacion y educacion en planificacion familiar.]
  94. Information provided with oral contraceptives [letter]
  95. Initial report: Expert Committee on Training in Voluntary Surgical Contraception, Rio de Janeiro, Brazil, September 26-29, 1984.
  96. Initiating contraceptive use: how do young women decide?
  97. Injectable contraception.
  98. Injectable contraceptives.
  99. Innovative approaches to reaching young people in health and family planning programmes.
  100. Insertion of intrauterine contraceptive device in a patient with a ventricular septal defect: need for antibiotic prophylaxis.
  101. Instructions for starting the use of oral contraceptives [letter]
  102. Instructions on sexual activities and contraception.
  103. Integrated family planning services: a Nigerian experience.
  104. Integrating health service components into a comprehensive family planning and basic MCH programme: lessons from the Matlab Family Planning Health Services Project.
  105. Integration and development of family planning within health services, for the promotion of maternal and child health in Niger. Excerpts. [Integration et developpment du planning familial dans les services sanitaires, pour une promotion de la sante de la mere et de l'enfant au Niger.]
  106. The integration of family planning and primary health care: lessons from operational research studies.
  107. Integration of family planning into primary health care service in Ogun State.
  108. Integration of family planning with national health services. Integration de la planification familiale aux services nationaux de sante.
  109. The integration of health, nutrition and family planning services.
  110. Interaction between oral contraceptives and griseofulvin.
  111. Interaction of drugs with oral contraceptive steroids.
  112. Interindividual variability in oral contraceptive disposition.
  113. International experience with Norplant contraceptive implants.
  114. International health and family planning. Policy issues--consensus and controversies.
  115. International Seminar on Islam and Family Planning, final report. [Seminaire international sur l'Islam et la planification famille, rapport final.]
  116. Interval voluntary surgical contraception has advantages for Sub-Saharan Africa.
  117. Intrauterine contraception with copper and with levonorgestrel: randomized study of the TCu 380Ag and levonorgestrel 20 mcg/day devices.
  118. Intrauterine contraception. [Contraception intra-uterine.]
  119. Intrauterine contraception. [Die intrauterine Kontrazeption.]
  120. Intrauterine contraceptive device localization by clinical evaluation and real-time ultrasonography.
  121. Intrauterine contraceptive device use, anti-inflammatory drugs and arthritis.
  122. Intrauterine contraceptive devices--malignant tumors of the uterus. [Mehen beluli fogamzasgatlo eszkozok--uterus malignomak.]
  123. The intrauterine device: a contraceptive without problems? [Das Intrauterinpessar ein problemloses Kontrazeptivum?]
  124. An intravaginal contraceptive device for the delivery of an acrosin and hyaluronidase inhibitor.
  125. Introduction to family planning.
  126. Inventory of selected local family planning programme experiences in countries of the ESCAP region. Volume VI.
  127. An investigation into environmental factors affecting the marketing of social change: the case of family planning in less developed countries.
  128. Investigations on Dieffenbachia-Amoena Gentil. 1. Endocrine effects and contraceptive activity.
  129. IPPF consultation on male involvement in family planning: the Ghanaian experience.
  130. IPPF Francophone Africa consultation men and family planning (summary report)
  131. Is voluntary abortion now to be regarded as a a contraceptive? [L'aborto volontario, oggi, e da considerarsi un contraccettivo?]
  132. Is voluntary abortion to be regarded now as a contraceptive? [L'aborto volontario, oggi, e da considerarsi un contraccettivo?]
  133. Islam and family planning in Africa.
  134. Isotretinoin and contraception [letter]
  135. Judging risks versus benefits of oral contraceptives [editorial]
  136. Just the right size: a guide to family-size planning.
  137. Kenya Contraceptive Prevalence Survey, 1984, first report.
  138. Kenya: assessment of current voluntary surgical contraception services and potential for expansion. Association for Voluntary Sterilization.
  139. The King's Birthday Vasectomy Festival: a world record for male voluntary surgical contraception.
  140. Knowledge and attitudes of adolescents toward birth control. [Informisanost i stavovi adoloscenata o regulaciji fertiliteta.]
  141. Knowledge and practice of contraception in two Indochinese refugee camps.
  142. Knowledge of contraception and use of contraceptive methods among college students in a major Southeastern public university.
  143. Knowledge, attitude and practice of family planning in Hausa women.
  144. Knowledge, attitudes and communication patterns with respect to family planning among Blacks in Ikageng. [Die kennis, houdings en kommunikasiepatrone van Swartes in Ikageng ten opsigte van gesinsbeplanning.]
  145. Lack of an elevated risk of malignant melanoma in relation to oral contraceptive use.
  146. Latest developments in contraception [letter]
  147. Law and family planning.
  148. Law and family planning.
  149. Lay concepts of reproductive physiology related to contraceptive use: a method of investigation.
  150. LH-RH analogs in contraception and cancer.
  151. LH-RH nasal spray in contraception.
  152. LHRH agonists for female contraception.
  153. LHRH and analogs: reproductive pharmacology and contraceptive and therapeutic utility.
  154. Limitations of the indicator-total fertility--as suggested by the real situation of family planning in our District.
  155. Local production of contraceptives in developing countries.
  156. Long-acting contraceptive delivery systems.
  157. Long-acting injectable norethisterone contraceptive system: review of clinical studies.
  158. Long-term suppression of hypermenorrhea by progesterone intrauterine contraceptive devices.
  159. Long-term survival after resection of a hepatocellular carcinoma with lymph node metastasis and discontinuation of oral contraceptives.
  160. Long-term treatment with combined oral contraceptives and cigarette smoking associated with impaired activity of tissue plasminogen activator.
  161. Luteinizing hormone releasing hormone analogues for contraception.
  162. Maculate contraception.

     

  163. Major research findings in 1984. Unmarried female factory workers' knowledge, attitude on sexual and contraceptive behaviours.
  164. Maker of contraceptive sponge responds to toxic shock reports.
  165. Malaria control and family planning: a look at two programs aimed at the grassroots.
  166. Male adolescent birth control behavior: the importance of developmental factors and sex differences.
  167. Male attitudes towards family planning in Khartoum, Sudan.
  168. Male contraception today.
  169. Male contraception. [La contraception masculine.]
  170. Male involvement in family planning (need--experience)
  171. Male involvement in family planning in the Arab World Region.
  172. Male involvement in family planning: an ESEAOR perspective.
  173. Male involvement in family planning: programme initiatives.
  174. Male involvement in family planning: report of an IPPF staff consultation.
  175. Male involvement in family planning: trends and directions.
  176. Male knowledge and use of contraception in three Caribbean islands: results from the 1983 Contraceptive Prevalence Survey [tables]
  177. Males and contraception: the relationship between contraceptive knowledge, attitudes, and behavior.
  178. Management and administrative structure and practices of Yemen Family Planning Association.
  179. Management in family planning programs: literature, concepts and research agenda.
  180. Management of the national family planning programme in Indonesia.
  181. Mandatory parental involvement in contraceptive services for minors.
  182. Marital conflict and contraceptive choice [tables]
  183. Mass use of injectable contraceptive.
  184. Massive hemoperitoneum from rupture of richly vascularized benign liver tumours in women on oral contraceptives [letter]
  185. Maternal and child health and family planning services in Menoufia and Beni Suef Governorates, Egypt.
  186. The maternal child health and family planning programme in Kenya.
  187. Maternal-child health and family planning. [Salud maternoinfantil y planificacion familiar.]
  188. Maternal-infant protection. Family planning: annual report 1983. [Protection materno infantile. Planification familiale: rapport annuel, 1983.]
  189. The measurement of family planning program effort. Preliminary report.
  190. The measurement of family planning program effort: who wears the rose-colored glasses?
  191. The measurement of unmet need for family planning in developing countries.
  192. Measuring accessibility to family planning services in rural Thailand.
  193. Measuring the performance of family planning clinics: an index of efficiency.
  194. Media planning in contraceptive social marketing.
  195. The medical aspects of birth control.
  196. Medical counseling and activities of the Specialty Committee--final conclusions drawn from current trends in irreversible contraception. [Arztliche Beratung und Fachkommissionstatigkeit-Schlussfolgerungen aus aktuellen Tendenzen bei der irreversiblen Kontrazeption.]
  197. Medical education of family planning to physicians.
  198. The medical management of effects of contraceptive failure conference, April 3-4, 1984, Meridien Hotel, Cairo.
  199. Meeting the needs of the 1980s for Voluntary Surgical Contraception. A report on the Fifth International Conference on Voluntary Surgical Contraception December 5-8, 1983.
  200. Men and contraception in the UK.
  201. Men and family planning in Africa. Les hommes et la planification familiale en Afrique.
  202. The menstrual cycle from a bio-behavioral approach: a comparison of oral contraceptive and non-contraceptive users.
  203. Menstrual regulation and contraception in Bangladesh: competing or complementary?
  204. Menstrual regulation: its effect on family planning.
  205. Mesenteric vein thrombosis associated with oral contraceptive administration during pregnancy.
  206. Metabolic effects of low dose combined oral contraceptives.
  207. Metabolic effects of oral contraceptives and long-term safety.
  208. Metabolism of 14-C-arachidonic acid in platelets and antiaggregatory potency of prostacyclin in women taking oral contraceptives.
  209. Methods of birth control. Choice is yours.
  210. Mexico's soap operas carry message about birth control.
  211. Mexico: comparison of contraceptive distribution systems SIN 0749-1149: final report.
  212. Mexico: resources, population, family planning. [Mexico: recursos, poblacion, planeacion familiar.]
  213. Microbiological and histological findings in the fallopian tubes of women using various contraceptive methods.
  214. Microencapsulation of contraceptive steroids.
  215. Migraine and hormonal contraceptives. [Migrane und hormonelle Antikonzeptiva.]
  216. Migrants and planned parenthood.
  217. The Ministry of Interior's (MOI) support for family planning.
  218. A model for the comparative analysis of WFS contraceptive use data.
  219. A model of premarital coitus and contraceptive behavior among female adolescents. [Modele pour l'etude du comportement des adolescentes concernant les rapports premaritaux et la contraception.]
  220. Monoclonal sperm antibodies: their potential for investigation of sperms as target of immunological contraception.
  221. More about natural family planning [letter]
  222. More about natural family planning. The author replies [letter]
  223. More family planning and abortion services needed.
  224. Morphological changes in tubal mucosa associated with the use of intrauterine contraceptive devices.
  225. Motives for pregnancy and parenthood. An empirical study of women using contraceptives. [Motive zu Schwangerschaft, Geburt und Elternschaft. Ergebnisse einer empirischen Untersuchung an verhutungswilligen Frauen.]
  226. Moyamoya. An association with birth control pills.
  227. A multilevel model of family planning availability and contraceptive use in rural Thailand.
  228. A multivariate analysis of family planning knowledge differentials in rural Ghana (West Africa)
  229. Multivariate analysis of family planning variables: a review of the literature.
  230. Myasthenia and oral contraceptives (a case report) [Myasthenie und orale Kontrazeptiva (Ein kasuistischer Beitrag)]
  231. Myths on contraceptive use.
  232. The National Center for Information and Documentation Network on the National Family Planning Programme.
  233. National Contraceptive Prevalence Survey, summary, Dominican Republic, 1983. [Encuesta Nacional de Prevalencia de Anticonceptivos, resumen, Republica Dominicana, 1983.]
  234. National Contraceptive Prevalence Survey. Men. Report of findings. [Encuesta Nacional de Prevalencia de Anticonceptivos--hombres. Informe de resultados.]
  235. The National Family Planning Program: its impact on perinatal mortality.
  236. National Survey on Fertility and Family Planning in Morocco 1979-80. National report. Volume I. Country presentation and survey methodology. [Enquete Nationale sur la Fecondite et la Planification Familiale au Maroc 1979-80. Rapport national. Volume I--presentation du pays et methodologie de 'enquete.]
  237. National Survey on Fertility and Family Planning in Morocco 1979-80. National report. Volume II. Population and health: findings of the Household Survey. [Enquete Nationale sur la Planification Familiale au Maroc 1979-80. Rapport national. Volume II--population et sante: resultats de l'Enquete Menage.]
  238. National Survey on Fertility and Family Planning in Morocco 1979-80. National report. Volume IV. Statistical tables. Demographic characteristics. [Enquete Nationale sur la Fecondite et la Planification Familiale au Maroc 1979-80. Rapport national. Volume IV--tableaux statistiques. Caracteristiques demographiques.]
  239. National Survey on Fertility and Family Planning in Morocco 1979-80: summary of findings. [Enquete Nationale sur la Fecondite et la Planification Familiale au Maroc 1979-80: resume des resultats.]
  240. National Survey on Fertility and Family Planning in Morocco, 1979-80. National report. Volume III. Population dynamics, health and family planning. Findings of the Individual Survey. [Enquete Nationale sur la Fecondite et la Planification Familiale au Maroc 1979-80. Rapport national. Volume III--dynamique de population, sante et planification familiale: resultats de l'Enquete Individuelle.]
  241. Natural birth control: a practical guide to fertility awareness.
  242. Natural family planning (NFP) [Naturliche Familienplanung (NFP)]
  243. Natural family planning (NFP) in India: an overview.
  244. Natural family planning (symptothermal method) and objective ovulation indicators--a pilot study. [Naturliche Familienplanung (symptothermale Methode) und objektive Ovulations parameter--eine Pilotstudie.]
  245. Natural family planning and hormonal assays in Japan.
  246. Natural family planning as reflected in contemporary rabbinic response.
  247. Natural family planning in Kenya: an assessment.
  248. Natural family planning in Mauritius, Indian Ocean: utilization patterns and continuance predictors.
  249. Natural family planning in the Philippines.
  250. Natural family planning methods and comprehensive health care systems. Project summary.
  251. Natural family planning programme--a project of Caritas Bangladesh.
  252. Natural family planning: development of national programs.
  253. A natural method of family planning.
  254. Natural methods of family planning.
  255. Need for and acceptability of long-acting steroidal contraception.
  256. Needs and priorities in psychosocial and services research in family planning. [Necesidades y prioridades en la investigacion psicosocial y de servicios en planificacion familiar.]
  257. Needs assessment in family planning: a guide for program development.
  258. Needs assessment: maternal and child health and family planning, Democratic People's Republic of Korea.
  259. New contraceptives by the year 2000: promise and challenge.
  260. New devices for intrauterine contraception.
  261. New findings to avoid failures when applying the rhythm method of contraception.
  262. A new progestin for contraceptive combination. [Une nouvelle molecule progestative dans une association contraceptive. Le desogestrel.]
  263. Nexus: across the border cooperation for MCH and family planning.
  264. Nodular regenerative hyperplasia, hepatocellular carcinoma and oral contraceptives (letter) [Hyperplasie nodulaire regenerative, carcinome hepatocellulaire et contraceptifs oraux.]
  265. Non-contraceptive benefits of oral contraceptives--good news for a change.
  266. Norethisterone oenanthate as an injectable contraceptive in two treatment schedules in interval subjects.
  267. Norethisterone oenanthate: the other injectable contraceptive. A briefing paper.
  268. NORPLANT contraceptive implants advancing.
  269. Norplant contraceptive implants.
  270. Norplant subdermal contraceptive implants: an overview.
  271. Nuptiality, fertility and family planning practices in rural Bangladesh.
  272. Nursing protocol for diaphragm contraception.
  273. Nutrition education for family planning workers. [Educacion sobre nutricion para trabajadores de planificacion familiar.]
  274. Observation: contraceptive method use following an abortion.
  275. On family planning and socialist cultural civilization.
  276. On the acceptability of different methods of family planning in India: 1971-1980.
  277. Operation of the family planning program in the urban environment. [Operacion del programa de planificacion familiar en el medio urbano.]
  278. Operational responses to the World Population Plan of Action in programmes of the UNFPA in the areas of fertility, family and family planning.
  279. Operationalizing the Luker concept of contraceptive risk-taking behavior.
  280. Operations research in family planning and maternal child health.
  281. Operations research in family planning programs. [Investigacion operativa en programas de planificacion familiar.]
  282. Oral contraception and cancer of the breast. [Cancer du sein: influence de la contraception hormonale.]
  283. Oral contraception and circulatory risks. [Contraception orale et risques circulatoires.]
  284. Oral contraception and metabolism. [Contraception orale et metabolismes.]
  285. Oral contraception in Bangladesh.
  286. Oral contraception in Denmark in 1983. [P-pillebrug i Danmark i 1983.]
  287. Oral contraception in the National Population/Family Planning Program in Indonesia.
  288. Oral contraception in the Philippines.
  289. Oral contraception: failures and risks. [Echecs et dangers de la contraception orale.]
  290. Oral contraceptive agents do not affect serum prolactin in normal women.
  291. Oral contraceptives in Bangladesh.
  292. Oral contraceptives in Taiwan.
  293. Oral contraceptives, postmenopausal oestrogen-progestagen use and breast cancer.
  294. Oral contraceptives, pregnancy, and endogenous estrogen in all stone disease [letter]
  295. Oral contraceptives.
  296. Oral contraceptives.
  297. Oral contraceptives: the risks in perspective.
  298. Organized family planning services in the United States, 1981-1983.
  299. An outline on the Role of Leadership Groups in Gaining Acceptance of Family Planning Workshop to be held on Wednesday, November 7, 1984, Freetown, Sierra Leone.
  300. Overcoming obstacles to family planning.
  301. An overview of use and source of contraception in Latin America.
  302. The Ovulation Method of family planning.
  303. The Oxford-Family Planning Association Contraceptive Study.
  304. Oyo state, Nigeria, CBD Health/Family Planning project. Baseline survey: preliminary results, March, 1984.
  305. Pakistan Contraceptive Prevalence Survey, individual questionnaire.
  306. Perception of family planning service availability in rural Malaysia.
  307. Perceptions of contraceptive methods: a multidimensional scaling analysis.
  308. The performance of India's family planning programme.
  309. Personal networks and the adoption of family planning in rural Korea.
  310. Perspectives for the development of new contraceptives.
  311. Pharmacodynamics of a contraceptive vaginal ring releasing norethindrone and estradiol: ovarian function, bleeding control and lipoprotein patterns.
  312. Pharmacokinetic interaction of contraceptive steroids with prednisone and prednisolone.
  313. Pharmacokinetics and "potency" of contraceptive steroids [letter]
  314. Pharmacological basis of therapeutics: gossypol, an oral male contraceptive?
  315. The Philippines: profiles--problems--prospects on population and family planning.
  316. Planned parenthood and women's development in the Indian Ocean Region: experience from Bangladesh, India and Pakistan.
  317. Plasma pyridoxal phosphate in women taking oral contraceptives since at least five years.
  318. Plasma renin substrate, renin activity, and aldosterone levels in a sample of oral contraceptive users from a community survey.
  319. Political capacity, development and family planning programs in developing countries: a cross-national analysis.
  320. The politics of contraception.
  321. Polymeric considerations in the design of microencapsulation of contraceptive steroids.
  322. Population and family planning of minority groups.
  323. Population and family planning programs in Asia: 1974-1984.
  324. Population and family planning: the role of media.
  325. Population and intersectoral activities: delivering family planning services in the "spirit of Bucharest".
  326. Population dynamics, family planning and population policy in Costa Rica. [Dinamica demografica, planificacion familiar y politica de poblacion en Costa Rica.]
  327. The Population Family Planning Program in Egypt: structure and performance.
  328. Population policy and family planning programs in Peru. [Politica de poblacion y programas de planificacion familiar en el Peru.]
  329. Porphyria and hormonal contraceptives. [Porphyrie und hormonale Kontrazeptiva.]
  330. Position paper on family planning.
  331. Possible antidepressant effect on oral contraceptives: case report.
  332. Possible protection from breast cancer with long-term oral contraceptive use.
  333. Possible role of mast cells in the mechanism of action of intrauterine contraceptive devices.
  334. Post-coital contraception.
  335. Post-coital contraception.
  336. Postcoital contraception (without prostaglandins) [Die postkoitale Kontrazeption (ohne Prostaglandine)]
  337. Postcoital contraception with intranasal buserelin.
  338. Postcoital contraception.
  339. Postcoital contraception. [Contraception post-coitale.]
  340. Postcoital contraception. [Contraception postcoitale.]
  341. Postcoital contraception: a delicate political issue.
  342. Postcoital contraception: awareness of the existence of postcoital contraception among students who have had a therapeutic abortion.
  343. Postcoital contraception: student choices and effectiveness.
  344. Postcoital contraceptive efficacy and hormonal profile of Lepidium capitatum.
  345. Postcoital intervention: a family-planning-clinic experience of 213 cases.
  346. Postpartum amenorrhea in selected developing countries: estimates from contraceptive prevalence surveys.
  347. Postpartum and postabortum contraception. [La contraception durant le post-partum et le post-abortum.]
  348. Postpartum contraception. [Anticonceptie post partum.]
  349. Potential place of implants in the Egyptian family planning programme.
  350. Potential risks, benefits of progestins in birth control pills outlined.
  351. Poverty, family planning, and health.
  352. Predicting contraceptive behavior among university men: the role of emotions and behavioral intentions.
  353. Predicting family planning behavior from health behavior: policy implications for integration.
  354. Predicting male and female contraceptive behavior: a discriminant analysis of groups high, moderate, and low in contraceptive effectiveness.
  355. Predicting the adoption of contraception: a multivariate analysis of contraceptive intentions and subsequent use in Matlab Thana, Bangladesh.
  356. Pregnancy intervals, breast-feeding and contraception.
  357. A preliminary investigation on a thread embedded into the vas deferens through percutaneous puncture for contraception [abstract]
  358. The prescription of contraception: negotiations between doctors and patients.
  359. The presence of others during the interview and the reporting of contraceptive knowledge and use.
  360. The present situation in hormonal contraception.
  361. Prevalence of knowledge and use of contraception in Pakistan.
  362. The prevention of procreation: contraception.
  363. Prevention of prothrombotic effects of oral contraceptives by use of Vitamin B6. [Prevence protrombotickeho ucinku oralniho kontraceptiva vitaminem B6.]
  364. Price elasticity and cost recovery experience in LDC family planning programs.
  365. Pricing and cost recovery experience in family planning programs: a review of evidence.
  366. Primary health care and family planning in the rural environment. [Atencion primaria de la salud y planificacion familiar en el medio rural.]
  367. Primary ovarian pregnancy and the intrauterine contraceptive device. A case report.
  368. The problem of contraceptive failure.
  369. Problems of contraception in female teenagers. [Probleme der Schwangerschaftsverhutung weiblicher Jugendlicher.]
  370. Proceedings of the Sixteenth Annual Conference, Association for Population/Family Planning Libraries and Information Centers--International, the Pittsburgh Hilton, Pittsburgh, Pennsylvania, 12-14 April 1983. APLIC is alive and well and visiting Pittsburgh.
  371. Profile of contraceptive clients in Katsina, Northern Nigeria.
  372. Profits bar to safe contraception.
  373. Program implications of the contraceptive safety studies.
  374. Programme performance: the assessments of Asian family planning programmes.
  375. Project description and budget. Project number: Mauritius-02/Modification 8. Project title: Rodrigues Family Planning Project.
  376. Project evaluation report. Family planning pre-service training for doctors. Subproject (PIL 28), AID grant 263-0029.
  377. Project report: motivating women in the new community, "El Ermitano" towards better health and planned parenthood as a means to a better life. [Informe del proyecto: "motivacion a las mujeres en maternidad voluntaria y salud como un medio de alcanzar una mejor situacion de vida" en el Pueblo Joven "El Ermitano."]
  378. Prolactin, LH, FSH and TSH responses to a dopamine antagonist in subjects on oral contraceptives.
  379. Promoting family planning through the constitution.
  380. Promoting family planning: nurse's view point.
  381. Promoting male responsibility in family planning in the Africa Region.
  382. Promotion of the legal right to family planning. [La promocion legal del derecho a la planificacion familiar.]
  383. Proper indicators for evaluating family planning work.
  384. Prospect of family planning in fertility decline in rural West Bengal.
  385. Prospects for LHRH analogs as contraceptives.

     

  386. Prospects of family planning in rural Haryana.
  387. The provision of natural family planning methods through comprehensive health care systems: first report to AID/POP, April 1 - July 31, 1984.
  388. Proxies for birth control. Comment on Kelly and Cutright, Sociological Focus, April 1983.
  389. The psychology of adolescent contraceptive neglect: theory, research, and proposed interventions.
  390. Psychosomatic complications of contraception. [Psychosomaticke komplikace antikoncepce.]
  391. Putting the sex back into contraception.
  392. A qualitative assessment of attitudes towards and usage of contraceptives among Jamaican females.
  393. A qualitative assessment of attitudes towards and usage of contraceptives among Jamaican males.
  394. Quarterly versus monthly supervision of CBD family planning programs.
  395. A quest for better contraception: the Ford Foundation's contribution to reproductive science and contraceptive development 1959-1983.
  396. Questions and answers about Title X and family planning.
  397. Randomised comparison of the use-effectiveness and patient acceptability of the Collatex (Today) contraceptive sponge and the diaphragm.
  398. Rapid increase in contraceptive rate: since 1981 new population control policy.
  399. Rapid onset of an increase in caffeine residence time in young women due to oral contraceptive steroids.
  400. Rationale for a triphasic oral contraceptive.
  401. Rationalizing management for family planning logistics in India.
  402. Reading profile on contraception, no. 5.
  403. Real and false risks of contraceptive information. [Risques vrais et faux de l'information contraceptive.]
  404. Real and false risks of hormonal contraceptives. [Risques vrais et faux de la contraception hormonale orale.]
  405. Real and false risks of male contraception. [Risques vrais et faux de la contraception masculine.]
  406. Reasons for not using contraceptives: an international comparison.
  407. Recent advances in combined oral contraception--lessons learnt from epidemiological studies.
  408. Recent changes in contraceptive use and fertility in Korea.
  409. Recent levels and trends of contraceptive use as assessed in 1983.
  410. Recent trends in contraceptive use prevalence and fertility in Matlab: possible implications of recent demographic dynamics for policy.
  411. Recognizing DMPA as a contraceptive [letter]
  412. Regulatory effect of contraceptive steroids on the release of tissue-type plasminogen activator in vitro.
  413. The relation between Trichomonas vaginalis and contraceptive measures.
  414. Relationship between contraceptive method and vaginal flora.
  415. The reliability of the contraceptive prevalence statistics of the Indonesian family planning program.
  416. Remission of hyperthyroidims and oral contraceptive therapy. [Answer to question]
  417. Renal disease and contraception.
  418. Reply to Sloan [on proxies for birth control]
  419. Report of the fifth annual workshop in family planning, nutrition, and primary health care for Africa: program design, management, and evaluation.
  420. Report of the First Study Directors' Meeting of the Pilot Study on the Role of Community Communication Networks in the Acceptance and Continuance of Family Planning Practice.
  421. Report of the panel of persons appointed by the Licensing Authority to hear the application by Upjohn Ltd. for a product license to market the drug Depo-Provera as a longterm contraceptive agent.
  422. Report on course on contraceptive technology update.
  423. Report on Management Course for Family Planning Programme Senior Staff, July 16 to August 10, 1984.
  424. Report on the Jamaica contraceptive prevalence survey 1983.
  425. Report on the survey of family planning knowledge, attitude and practice in Hong Kong 1982.
  426. Report: Workshop on Maternal and Child Health/Family Planning Indicators Relevant to South Pacific Countries, Suva, Fiji, 16-20 January 1984.
  427. Research designs for family planning field studies.
  428. Research needs in family planning program promotion.
  429. Research on factors related to the discontinuation of contraception: Coloured women in the metropolitan area of Capetown. ['n Ondersoek na faktore wat met kontraseptiewe staking verband hou: Kleurlingvroue in die metropolitaanse gebied van Kaapstad.]
  430. Research on maternal-child health and family planning, Amazonas, Brazil 1982. [Pesquisa sobre saude materno-infantil e planejamento familiar, Amazonas, Brasil 1982.]
  431. Research on maternal-child health and family planning, Piaui, Brazil 1982. [Pesquisa sobre saude materno-infantile planejamento familiar, Piaui, Brasil 1982.]
  432. Research on natural family planning in the Philippines.
  433. Research protocol: communities networks and family planning practice.
  434. A resourcebook for an integrated functional education and family planning project. Part I. A manual for the management of an integrated functional education and family planning project.
  435. A resourcebook for an integrated functional education and family planning project. Part II. Functional education teaching package (English version)
  436. Response from women to adverse publicity about oral contraceptives.
  437. Response to the paper by Richard Wiseman ["Absence of correlation between oral contraceptive usage and cardiovascular mortality"]
  438. A retrospective review of the South Sulawesi community development and family planning program.
  439. A review and analysis of population and family planning provisions in selected national development plans of the 1980's.
  440. A review of the implementation of oral contraception in Korea.
  441. A review of the Model Comprehensive Family Planning Clinic and Registration Bureau in Alexandria, Egypt.
  442. A review of three community-based distribution of contraceptives programmes in rural Kenya.
  443. Riboflavin, self-report, and serum norethindrone: comparison of their use as indicators of adolescent compliance with oral contraceptives.
  444. The risk approach in health care with special reference to maternal and child health, including family planning.
  445. Risks and benefits of using oral contraceptives.
  446. Risks of intrauterine contraceptive devices [letter]
  447. Risks of intrauterine contraceptive devices [letter]
  448. Risks of intrauterine contraceptive devices [letter]
  449. Risks of intrauterine contraceptive devices.
  450. Risks of new contraception methods. [Risques des nouvelles methodes en contraception.]
  451. Risks of oral contraceptives, in particular in diabetic women. [Les risques de la contraception hormonale, en particulier chez les femmes diabetiques.]
  452. Role of community leaders in the family planning program of Bangladesh.
  453. The role of leadership in gaining acceptance of family planning.
  454. The role of midwives in family planning practise in Turkey.
  455. The role of modern family planning in southwestern rural Nigeria.
  456. The role of national leadership groups in building support for all family planning methods.
  457. The role of sugar factories in rural development and family planning.
  458. The role of the Bangkok Metropolitan Administration in family planning and maternal and child health care in the slum areas.
  459. The role of the doctor in family planning.
  460. Role of women's organisation in gaining acceptance to family planning: [Nigeria]
  461. The role of women's organisations in gaining acceptance of family planning [Mauritius]
  462. The role of women's organizations in gaining access to family planning: [Mauritius]
  463. The Royal College of General Practitioners' Oral Contraception Study: some recent observations.
  464. S-adenosyl-L-methionine antagonizes oral contraceptive-induced bile cholestrol supersaturation in healthy women: preliminary report of a controlled randomized trial.
  465. Safety and side effects of contraceptives as they relate to Kenyan family planning activities.
  466. Safety of oral contraception: a quarrel with the recent literature.
  467. Safety of voluntary surgical contraception: report of an expert committee, Manila, May 9-12, 1983.
  468. Search for male contraceptive complicated by adverse effects.
  469. Seeking better contraceptives.
  470. Selected characteristics of "exposed" women who want no more children but were not using contraceptives.
  471. Self images and contraceptive behavior.
  472. Sensitivity of pituitary gonadotropins to luliberin in women using intrauterine contraceptive devices. [Issledovanie chuvstvitelnosti gonadotrofov gipofiza k liuliberinu u zhenshchin, polzuiushchikhsia vnutrimatochnymi kontratseptivami.]
  473. Serum total and unbound testosterone and sex hormone binding globulin (SHBG) in female acne patients treated with two different oral contraceptives.
  474. Service delivery, family planning promotion program in Taiwan, Republic of China.
  475. Serving contraceptive clients in developing countries.
  476. Serving human needs, preserving human rights/Planned Parenthood Federation of America, Inc. 1983 Annual Report.
  477. Severe and prolonged oral contraceptive jaundice.
  478. Sex and family planning: how we teach the young. Report on a study.
  479. Sex education and family planning services for adolescents in Latin America: the example of El Camino in Guatemala.
  480. Sex hormone binding globulin: its relevance to oral contraception.
  481. Sex hormones and related compounds, including oral contraceptives.
  482. Sexual and contraceptive experience among teenagers in Uppsala.
  483. Sexual behaviour and contraceptive practice at Oxford and Aberdeen Universities.
  484. Sexual information and contraception for adolescents. [Information sexuelle et contraception a l'adolescence.]
  485. Sexually active adolescents: implication for social work intervention and family planning services.
  486. Sexually transmitted diseases and family planning: strange or natural bedfellows?
  487. Steps being taken in Tanzania toward gaining acceptance for family planning and for including VSC as a family planning option.
  488. Sterilization acceptance and follow through; results from a family planning program in Brazil: a final report.
  489. Steroid intra-uterine contraception: progesterone-releasing devices. II. Insertion, clinical problems and contraceptive dependability. [Contraccezione intrauterina steroidea. Dispotivi liberanti progesterone. II. Inserzione, problemi clinici e sicurezza contraccettiva.]
  490. Strategies for implementing change in a rural health and family planning program in Bangladesh.
  491. Strategies to strengthen reproductive health. Contraceptive methods. [Estrategias para conservar la salud reproductiva. Metodos anticonceptivos.]
  492. Strengthening government health and family planning programs: findings from an action research project in rural Bangladesh.
  493. Structural approach to the evaluation of the quality of contraception services. [Strukturalni pristup proceni kvaliteta sluzbe za kontracepciju.]
  494. The study and evaluation of in-service training for Egyptian physicians in the field of family health and family planning, under the auspices of the High Institute of Public Health, Alexandria, Egypt.
  495. A study of family planning practice of four improved congested areas in Bangkok.
  496. A study of knowledge about attitude towards, and practice of family planning in Zambia.
  497. A study of self-administered contraceptive practice pattern in Korea.
  498. Study of serum levels of magnesium, calcium, zinc and iron in users of oral contraceptives.
  499. A study of the antithrombotic potential in women on oral contraceptives low in oestrogen. Its relation to the present knowledge of the mechanism and the pathophysiological aspects of the thrombo-haemorrhagic balance.
  500. A study on the cost effectiveness of the National Family Planning Programme in Sri Lanka, 1975-1981.

To view other lists of the current category of articles, please visit "Category Lists Homepage"


Web PubHealth.info

© Copyrights PubHealth.info®, an information portal on public health. All rights reserved.

This page is optimized to be viewed by Java script enabled Microsoft® Internet Explorer 6 or later version, at screen resolution of 800 by 600 pixels.